Methods and apparatuses for localizing myocardial infarction during catheterization

• US 7,640,046 B2
• Filed: 06/18/2004
• Issued: 12/29/2009
• Est. Priority Date: 06/18/2004
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Pastore, Joseph M., Girouard, Steven D.
• Primary Examiner(s): Schaetzle; Kennedy J.
• Assistant Examiner(s): SARCIONE, JESSICA LYNN
• Application Number:
  US10/871,865
• Publication Number:
  US 20050283195A1
• Time in Patent Office: 2,020 Days
• Field of Search: 607/116, 607/119, 607/122, 606/7, 606 10- 19, 606/2, 600/300, 600310-312, 600/481, 600/483, 600/508, 600/513, 600/301, 600407-408, 600410-411, 600420-421, 600431-433, 600473-480, 600319-337, 600/365, 600/315, 600341-342
• US Class Current: 600/342
• CPC Class Codes: A61B 2562/0219 Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0265 using electromagnetic means, e.g. electromagnetic flowmeter
• CPC Class Codes: A61B 5/1107 Measuring contraction of parts of the body, e.g. organ, muscle apparatus for measuring work or force in general G01L
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/6869 Heart
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371

Abstract

A catheter with a tissue property sensor provides for localization of myocardial infarction (MI) by utilizing one or more differences between properties of infarcted myocardial tissue and properties of normal myocardial tissue. The tissue property sensor is to be placed on endocardial wall or epicardial wall during catheterization to sense at least one tissue property allowing for detection of MI. Examples of the tissue property sensor include, but are not limited to, an optical sensor, an acoustic sensor, a contractility sensor, a temperature sensor, and a drug response sensor. In one embodiment, the tissue property sensor senses a tissue property in various locations on endocardial wall or epicardial wall and detects substantial changes in the tissue property that indicate a boundary between infarcted tissue and normal tissue.

Claims

1. A system for localizing myocardial infarction (MI) in a heart having a cardiac wall, the system comprising:

a transvenous catheter including a proximal end, a distal end, and a sensor link extending from the proximal end and the distal end, the distal end configured for endocardial placement on the cardiac wall;

a myocardial tissue property sensor incorporated into the distal end of the catheter, the myocardial tissue property sensor adapted to be placed in a plurality of locations, one at a time, over at least a portion of the cardiac wall to sense signals each indicative of at least one tissue property associated with one of the plurality of locations and each changing as a result of MI, the myocardial tissue property sensor including an optical sensor adapted to emit a light and receive the sensed signals; and

a tissue property analyzer configured to be connected to the proximal end of the catheter and coupled to the myocardial tissue property sensor via electrical connections of the sensor link, the tissue property analyzer adapted to produce a tissue property map presenting a measure of the at least one tissue property over the at least the portion of the cardiac wall using the sensed signals and further adapted to detect one or more infarcted regions using the tissue property map and a template spectrum associated with known infarcted tissue.

2. The system of claim 1, wherein the catheter comprises a diagnostic catheter adapted for assessment of hemodynamic function.

3. The system of claim 1, wherein the catheter comprises a diagnostic catheter adapted for mapping of cardiovascular structure.

4. The system of claim 1, wherein the catheter comprises a substance-delivery catheter.

5. The system of claim 1, wherein the catheter comprises an ablation catheter.

6. The system of claim 1, wherein the catheter comprises a pacing lead.

7. The system of claim 1, wherein the catheter comprises a defibrillation lead.

8. A system for localizing myocardial infarction (MI) in a heart having a cardiac wall, the system comprising:

a catheter including a proximal end, a distal end, and a sensor link extending from the proximal end and the distal end, the distal end configured for placement on the cardiac wall;

a myocardial tissue property sensor incorporated into the distal end of the catheter and adapted to be placed on the cardiac wall, the myocardial tissue property sensor including an optical sensor including;

an optical transmitter to emit a light; and

an optical receiver to receive an optical signal related to the emitted light, the optical signal indicative of a tissue property that changes as a result of MI; and

a tissue property analyzer adapted to be coupled to the proximal end of the catheter and including;

a wavelength analyzer adapted to produce an optical spectrum of the optical signal; and

an MI detector adapted to detect infarcted tissue by comparing the optical spectrum to a template spectrum obtained from an optical signal including fluorescence generated from tissue with elevated level of NADH; and

wherein the sensor link is configured to couple the myocardial tissue property sensor to the tissue property analyzer using electrical connections.

9. The system of claim 8, wherein the catheter comprises a lumen allowing injection of a fluorescent dye through the lumen, the fluorescent dye sensitive to transmembrane potentials.

10. The system of claim 9, wherein the catheter comprises a lead extending through at least a portion of the catheter and an electrode at or near the distal end, the electrode connected to the lead to allow delivery of electrical stimuli.

11. A system for localizing myocardial infarction (MI), the system comprising:

a transvenous catheter including a proximal end, a distal end, and a sensor link extending from the proximal end and the distal end, the distal end configured for endocardial placement;

a myocardial tissue property sensor incorporated into the distal end of the catheter, the myocardial tissue property sensor adapted to be placed in an endocardial location on a portion of an endocardial wall and including an optical sensor adapted to emit a light to the endocardial location and receive an optical signal related to the emitted light and indicative of at least one tissue property that changes as a result of MI in the endocardial; and

a tissue property analyzer adapted to be coupled to the proximal end of the catheter to receive the optical signal received by the optical sensor, the tissue property analyzer adapted to produce an optical spectrum of the received optical signal and further adapted to detect infarcted tissue by comparing the optical spectrum of the received optical signal to a template spectrum obtained from an optical signal including fluorescence generated from tissue with elevated level of NADH,

wherein the sensor link is configured to couple the myocardial tissue property sensor to the tissue property analyzer via electrical connections.

12. The system of claim 11, wherein the catheter comprises a lumen allowing injection of a fluorescent dye through the lumen, the fluorescent dye sensitive to transmembrane potentials.

13. The system of claim 12, wherein the

catheter comprises a lead extending through at least a portion of the catheter and an electrode at or near the distal end, the electrode connected to the lead to allow delivery of electrical stimuli.

14. A system for localizing myocardial infarction (MI), the system comprising:

a transvenous catheter including a proximal end, a distal end, and a sensor link extending from the proximal end and the distal end, the distal end configured for endocardial placement;

a myocardial tissue property sensor adapted to sense an optical signal indicative of at least one tissue property that changes as a result of MI, the myocardial tissue property sensor incorporated into the distal end of the catheter and adapted to be placed in a plurality of endocardial locations, one at a time, over at least a portion of an endocardial wall to sense optical signals each indicative of the at least one tissue property for one of the plurality of endocardial locations; and

a tissue property analyzer adapted to be connected to the proximal end of the catheter and receive the sensed optical signals via electrical connections of the sensor link, the tissue property analyzer including;

a tissue property mapping module adapted to produce a tissue property map presenting a measure of the at least one tissue property over at least the portion of the endocardial wall based on the sensed optical signals; and

an MI detector adapted to detect one or more infarcted regions based on the tissue property map and a template spectrum obtained from an optical signal including fluorescence generated from tissue with elevated level of NADH.

15. The system of claim 14, wherein the catheter comprises a lead extending through at least a portion of the catheter and an electrode at or near the distal end, the electrode connected to the lead to allow delivery of electrical stimuli.

16. The system of claim 15, wherein the optical sensor comprises:

an optical transmitter to emit a light; and

an optical receiver to receive an optical signal related to the emitted light.

17. A method for localizing myocardial infarction (MI) in a heart having an endocardial wall, the method comprising:

introducing a transvenous catheter including a proximal end, a distal end, and an optical sensor incorporated into the distal end by transvenous catheterization to provide for access to the endocardial wall of the heart;

placing the optical sensor in endocardial locations over a portion of the endocardial wall;

sensing optical signals in the endocardial locations using the optical sensor, the optical signals each indicative of at least one tissue property associated with the endocardial locations;

receiving the sensed optical signals using a tissue property analyzer via electrical connections coupling the optical sensor to the tissue property analyzer, the tissue property analyzer connected to the proximal end of the catheter;

producing parameters based on the received sensed signals using the tissue property analyzer, the parameters representative of the at least one tissue property for the endocardial locations producing a tissue property map using the tissue property analyzer, the tissue property map presenting the parameters representative of the at least one tissue property over the portion of the endocardial wall; and

detecting one or more infarcted regions based on the tissue property map using the the parameters and a template spectrum obtained from an optical signal including fluorescence generated from tissue with elevated level of NADH.

18. The method of claim 17, wherein detecting the one or more infarcted regions comprises identifying where substantial changes in the parameter representative of the at least one tissue property occur on the tissue property map.

19. A method for localizing myocardial infarction (MI) in a heart, the method comprising:

introducing a transvenous catheter including an optical sensor by transvenous catheterization to provide for access to the heart;

placing the optical sensor in an endocardial location in the heart;

emitting a light from the optical sensor;

receiving an optical signal related to the emitted light, the optical signal indicative of a tissue property in the endocardial location;

producing an optical spectrum of the received optical signal;

obtaining a template spectrum associated with known infracted tissue from an optical signal including fluorescence generated from tissue with elevated level of NADH; and

detecting infarcted tissue by comparing the optical spectrum to the template spectrum.

20. The method of claim 19, further comprising injecting a fluorescent dye sensitive to transmembrane potentials to the endocardial location.

21. The method of claim 19, further comprising delivering subthreshold electrical stimuli to the endocardial location.

22. The method of claim 19, wherein detecting the infarcted tissue comprises detecting the infarcted tissue when the optical spectrum matches the template spectrum within a predetermined margin.

23. The method of claim 19, further comprising repeating the emitting the light, receiving the optical signal, and producing the optical spectrum for a plurality of endocardial locations, wherein detecting the infarcted tissue comprises detecting the infarcted tissue based on the optical spectra produced for the plurality of endocardial locations.